Delhi High Court quashes Centre's notification to ban FDC drugs

By
| Thursday, December 1, 2016 - 12:42
First Published |
Latest News, Politics, Indian politics, Delhi High Court, Centre's notification to ban 344 fixed dose combination (FDC) medicines, endanger patient safety

Delhi High Court quashes Centre's notification to ban FDC drugs | Image for pictorial representation

New Delhi: The Delhi High Court on Thursday quashed the Centre's notification to ban 344 fixed dose combination (FDC) medicines.
 
The brands included D'Cold Total, Corex cough syrup, and Vicks Action 500, among others.
 
Justice R.S. Endlaw, allowing the 454 pleas filed by the pharma companies, quashed the Centre's notification issued on March 10.
 
Companies like Pfizer, Glenmark, Procter and Gamble, Reckitt Benckiser, Cipla and others had moved the court against the government decision. The court had granted stay on the notification.
 
The government had told the court that FDC medicines sold by pharma majors "endanger patient safety".
 
It had banned the drugs on the ground that they involve risk to humans and hence needed to be withdrawn immediately and contended that safer alternatives were available.
 
The pharma companies had argued that the ban order was passed without considering clinical data and had termed the government's claim as absurd.
 
 
 
Download English News App and stay updated with all Latest News.
For News in English, follow us on Google+, Twitter and on Facebook.
 

Add new comment

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.